MIMs (My Intelligent Machines) helps pharmaceutical, biotech and agri-tech companies analyze a staggering amount of genomic, clinical or phenotypic and environmental megadata. It also helps them leverage systems biology and machine learning to develop more efficient, personalized and environmentally friendly medical and agricultural practices.
Why we invested ?
The recent reduction in sequencing costs is pushing genomics into its industrial era of having BioPharma and Agritech use OMIC data. These companies need to turn OMIC data into actionable knowledge to capture trends called biomarkers. These biomarkers will be used to build clinical tests used in hospitals and predictive tools used on farms.
MIMs AI platform acts as an artificial assistant managing massive amounts of data aggregated from different public databases and provides life scientists with the required expertise in bioinformatics and data science.